Figure 6.Quantitively analyze the overall survival of patients with bladder cancer. (A) Nomogram considering risk score and several common-used clinicopathological factors. Calibration curves for 1-yaer (B), 3-years (C), 5-years (D).
Figure 6 — Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer | Aging
